Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Profound Medical to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Orthofix to Present at Canaccord Genuity Growth Conference
-
Shopify (SHOP) PT Raised to $165 at Canaccord Genuity
-
MasTec Senior Management at Canaccord Genuity and Jefferies Investor Conferences in Boston and New York
-
Merit Medical to Present at Two Conferences in August
-
Kornit Digital to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Datawatch To Participate in Canaccord Genuity 38th Annual Growth Conference
-
Ameresco to Present at 38th Annual Canaccord Genuity Growth Conference in Boston on August 8
-
Pear Therapeutics to Present at Canaccord Genuity 38th Annual Growth Conference
-
Xeris Pharmaceuticals to Present at Two Upcoming Investor Conferences
-
Oncolytics Biotech® to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Xeris Pharmaceuticals to Present at Two Upcoming Investor Conferences
-
REISSUE - ABcann to Acquire Leading B.C. Producer Canna Farms
-
Oncolytics Biotech® to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Interim Results
-
ABcann to Acquire Leading B.C. Producer Canna Farms
-
Aegion Corporation to Present at Upcoming Investor Conferences
-
Atlassian to Present at Upcoming Investor Conferences
-
Kratos to Present at the Canaccord Genuity Growth Conference
-
Aspen Aerogels to Present at the Canaccord Genuity Growth Conference
-
Veracyte to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Tactile Medical to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Merit Medical Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
Boston Scientific to Participate in 38th Annual Canaccord Genuity Growth Conference
-
Maricann Group Announces Amendment to Terms of Private Placement
-
Quanterix to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Apricus Biosciences (APRI) Announces Merger Agreement with Seelos Therapeutics
-
Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders
-
Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders
-
DLH to Present at the Canaccord Genuity Conference on August 8
-
Twitter, Inc. (TWTR) PT Raised to $32 at Canaccord Genuity Following Solid 2Q
-
Zimmer Biomet (ZBH) PT Raised to $125 at Canaccord Genuity
-
resTORbio to Present at the Canaccord Genuity 38th Annual Growth Conference
-
resTORbio to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Hydrogenics to Present at Canaccord Genuity Conference
-
Helios and Matheson (HMNY) Issues $5M Demand Note to Pay Merchant and Fulfillment Processors
-
Inseego Corp. to Present at 38th Annual Canaccord Genuity Growth Conference
-
Ducommun Announces Upcoming Investor Events
-
EverQuote to Present at Upcoming Investor Conferences
-
EverQuote to Present at Upcoming Investor Conferences
-
Halozyme Therapeutics To Participate In Upcoming Healthcare Conference
-
Senseonics to Participate in the Canaccord Genuity Growth Conference
-
Glu to Participate in the Canaccord Genuity 38th Annual Growth Conference
-
Chembio Diagnostics to Participate in the Canaccord Genuity Growth Conference
-
iRhythm Technologies to Present at the Canaccord Genuity 38th Annual Growth Conference
-
iRhythm Technologies to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Renewable Energy Group to Present at Upcoming Conferences
-
Savara (SVRA) Prices 4.25M Share Common Offering at $11.50/Sh
-
Savara Announces Pricing of Public Offering of Common Stock
-
Paycom to Participate in Upcoming Investor Conferences

